Cutler Group LP Biogen Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	SELL	$275.25 - $318.06 $485,265 - $560,739	-1,763 Reduced 61.45%	1,106 $315,000
Q1 2023 May 01, 2023	SELL	$256.56 - $292.34 $5.57 Million - $6.35 Million	-21,709 Reduced 88.33%	2,869 $797,000
Q4 2022 Feb 07, 2023	BUY	$252.44 - $306.72 $2.02 Million - $2.46 Million	8,008 Added 48.33%	24,578 $6.81 Million
Q3 2022 Oct 25, 2022	BUY	$194.69 - $268.46 $1.27 Million - $1.75 Million	6,514 Added 64.78%	16,570 $4.42 Million
Q2 2022 Aug 04, 2022	BUY	$187.54 - $223.02 $1.54 Million - $1.83 Million	8,191 Added 439.2%	10,056 $2.05 Million
Q1 2022 Apr 14, 2022	SELL	$193.77 - $244.14 $1.82 Million - $2.29 Million	-9,387 Reduced 83.43%	1,865 $392,000
Q4 2021 Jan 18, 2022	BUY	$223.92 - $287.77 $2.37 Million - $3.05 Million	10,599 Added 1623.12%	11,252 $2.7 Million
Q3 2021 Oct 26, 2021	BUY	$282.99 - $369.05 $156,493 - $204,084	553 Added 553.0%	653 $184,000
Q2 2021 Jul 19, 2021	SELL	$259.0 - $414.71 $47,915 - $76,721	-185 Reduced 64.91%	100 $34,000
Q1 2021 Apr 26, 2021	BUY	$242.95 - $284.63 $20,650 - $24,193	85 Added 42.5%	285 $79,000
Q3 2020 Oct 27, 2020	SELL	$264.77 - $305.71 $339,964 - $392,531	-1,284 Reduced 86.52%	200 $56,000
Q2 2020 Jul 22, 2020	SELL	$258.66 - $342.55 $406,872 - $538,831	-1,573 Reduced 51.46%	1,484 $397,000
Q1 2020 May 07, 2020	SELL	$268.85 - $341.04 $886,398 - $1.12 Million	-3,297 Reduced 51.89%	3,057 $967,000
Q4 2019 Feb 06, 2020	BUY	$220.06 - $304.07 $975,525 - $1.35 Million	4,433 Added 230.77%	6,354 $1.89 Million
Q3 2019 Oct 28, 2019	BUY	$217.44 - $243.88 $352,470 - $395,329	1,621 Added 540.33%	1,921 $447,000
Q2 2019 Aug 09, 2019	SELL	$219.29 - $241.72 $328,935 - $362,580	-1,500 Reduced 83.33%	300 $70,000
Q4 2018 Feb 05, 2019	BUY	$278.5 - $352.75 $473,450 - $599,675	1,700 Added 1700.0%	1,800 $541,000
Q3 2018 Nov 07, 2018	SELL	$293.51 - $383.83 $28,176 - $36,847	-96 Reduced 48.98%	100 $35,000
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $3.33 Million - $4.71 Million	-12,802 Reduced 98.49%	196 $53,000
Q4 2017 Jan 17, 2018	SELL	$307.64 - $344.58 $11.4 Million - $12.7 Million	-36,897 Reduced 73.95%	12,998 $4.14 Million
Q3 2017 Oct 17, 2017	BUY	$281.15 - $329.69 $14 Million - $16.4 Million	49,895	49,895 $15.6 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account